These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 5606218)

  • 1. [Proposals for an outline of fibrinolytic-clearing therapy in coronary diseases].
    Ferliga G
    G Gerontol; 1967 Jul; 15(7):813-26. PubMed ID: 5606218
    [No Abstract]   [Full Text] [Related]  

  • 2. On the effectiveness of a combined clarifying-fibrinolytic therapy in the preventive and curative treatment of arteriosclerosis and its sequelae.
    Ferliga G
    G Gerontol; 1966 Jun; 14(6):555-69. PubMed ID: 5989598
    [No Abstract]   [Full Text] [Related]  

  • 3. [Proposals for a plan of fibrinolytic-clearing therapy of peripheral obstructive arteriopathy].
    Ferliga G
    G Gerontol; 1967 Aug; 15(8):955-71. PubMed ID: 4181505
    [No Abstract]   [Full Text] [Related]  

  • 4. [Notes on the more effective fibrinolytic effect of nicotinic acid in an extemporaneous drug association].
    Ferliga G
    G Gerontol; 1967 Jun; 15(6):737-42. PubMed ID: 5604105
    [No Abstract]   [Full Text] [Related]  

  • 5. [Combined fibrinolytic-clearing treatment in obliterative endareteritis in the aged patient].
    Baldoni E
    G Gerontol; 1967 Dec; 15(12):1477-89. PubMed ID: 5618944
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of certain anti-arteriosclerotic drugs on alimentary lipemia].
    Ruzyllo E; Szostak WB; Cybulska B; Nowak S
    Pol Tyg Lek; 1967 Dec; 22(50):1938-40. PubMed ID: 5584128
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effects of lipotropin on blood lipids in patients with myocardial infarct].
    Kedra M; Kolber-Postepska B; Miturzyńska-Stryjecka H
    Pol Tyg Lek; 1970 Aug; 25(33):1239-41. PubMed ID: 5506776
    [No Abstract]   [Full Text] [Related]  

  • 8. [Non-fractionated heparin versus low molecular weight heparin in acute coronary syndromes].
    González Pacheco H
    Arch Cardiol Mex; 2001; 71 Suppl 1():S63-8. PubMed ID: 11565348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinolytic activity in coronary artery disease and myocardial infarction, and the role of fibrinolytic therapy in coronary thrombosis.
    Menon IS
    Lab Pract; 1968 May; 17(5):592-4. PubMed ID: 5648576
    [No Abstract]   [Full Text] [Related]  

  • 10. [Miscleron in the treatment of patients with atherosclerosis of the coronary and cerebal vessels].
    Sivkov II; Kukes VG; Kirichenko LL; Fedosova NS; Ishmaeva KA
    Sov Med; 1971 Sep; 34(9):54-7. PubMed ID: 5121295
    [No Abstract]   [Full Text] [Related]  

  • 11. [The efficacity of adenosine triphosphoric acid in the treatment of patients with coronary cardiosclerosis].
    Belen'kiĭ AI
    Klin Med (Mosk); 1969 Feb; 47(2):61-7. PubMed ID: 5379262
    [No Abstract]   [Full Text] [Related]  

  • 12. [Protocols for the prevention and treatment of thromboembolic disease (III). Antithrombotic therapy in coronary disease. The Editorial Committee on Protocols (1)].
    Med Clin (Barc); 1994 Sep; 103(9):344-7. PubMed ID: 7967896
    [No Abstract]   [Full Text] [Related]  

  • 13. [The treatment of acute coronary syndromes of the "non-ST elevation" type with enoxaparin: the TIMI 11B study. Thrombolysis in Myocardial Infarct].
    Galli M
    Ital Heart J Suppl; 2000 Apr; 1(4):575-6. PubMed ID: 10832148
    [No Abstract]   [Full Text] [Related]  

  • 14. [Innovations in thrombolytic therapy in heart and coronary diseases].
    Bode C
    Hamostaseologie; 2007 Dec; 27(5):317. PubMed ID: 18060239
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of inflammatory conditions of the iris and ciliary body, accompanying fibrin exudation].
    Novoderezhkin VV; Egorov EA; Nesterov AP; Egorov AE; Abramov MV; Kasimov EM
    Vestn Oftalmol; 2002; 118(6):28-9. PubMed ID: 12506653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hormone therapy in geriatrics].
    Eckerström S
    Lakartidningen; 1969 Jan; 66(4):354-8. PubMed ID: 4305721
    [No Abstract]   [Full Text] [Related]  

  • 17. Direct versus indirect thrombin inhibition in percutaneous coronary intervention.
    Marmur JD
    J Invasive Cardiol; 2002 Apr; 14 Suppl B():8B-18B. PubMed ID: 11967386
    [No Abstract]   [Full Text] [Related]  

  • 18. [Blood coagulation problems in cardiologic intensive care].
    Lechner K; Korninger C; Fasching I
    Verh Dtsch Ges Herz Kreislaufforsch; 1983; 49():79-83. PubMed ID: 6666311
    [No Abstract]   [Full Text] [Related]  

  • 19. [Symptomatic therapy refractory myocardial ischemia in coronary heart disease. Chronic intermittent urokinase therapy and invasive therapeutic measures].
    Leschke M; Schoebel FC; Strauer BE
    Internist (Berl); 1996 Jun; 37(6):597-606. PubMed ID: 8767992
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fibrynolytic therapy of coronary disease].
    Sterkowicz S
    Przegl Lek; 1970 Sep; 26(9):702-6. PubMed ID: 5472558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.